[The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
作者信息
Humbert M
机构信息
Centre des maladies vasculaires pulmonaires, UPRES EA 2705, service de pneumologie et réanimation respiratoire, hôpital Antoine-Béclère, AP-HOP, université Paris-Sud, 157 rue de la Porte-de-Trivaux, 92140 Clamart, France.
出版信息
Rev Med Interne. 2007 Dec;28 Suppl 4:S273-6. doi: 10.1016/j.revmed.2007.09.012. Epub 2007 Oct 8.
PMID:17961866
Abstract
摘要
相似文献
1
[The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Rev Med Interne. 2007 Dec;28 Suppl 4:S273-6. doi: 10.1016/j.revmed.2007.09.012. Epub 2007 Oct 8.
2
Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value.
Eur Respir J. 2007 Mar;29(3):432-4. doi: 10.1183/09031936.00001607.
3
Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
Health Technol Assess. 2009 Oct;13(49):1-320. doi: 10.3310/hta13490.
4
[Pulmonary arterial hypertension and systemic sclerosis].
Presse Med. 2006 Dec;35(12 Pt 2):1929-37. doi: 10.1016/s0755-4982(06)74927-2.
5
Sildenafil in the treatment of pulmonary hypertension.
Vasc Health Risk Manag. 2006;2(4):411-22. doi: 10.2147/vhrm.2006.2.4.411.
6
[Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S311-4. doi: 10.1055/s-2006-957199.
7
Treatment of severe pulmonary hypertension secondary to scleroderma: a three-drug approach.
Intern Med. 2008;47(6):511-3. doi: 10.2169/internalmedicine.47.0565. Epub 2008 Mar 17.
8
Sildenafil for enhanced performance at high altitude?
Ann Intern Med. 2004 Aug 3;141(3):233-5. doi: 10.7326/0003-4819-141-3-200408030-00016.
9
An evidence-based approach to the management of pulmonary arterial hypertension.
Curr Opin Cardiol. 2006 Jul;21(4):385-92. doi: 10.1097/01.hco.0000231410.07426.9b.
10
Summaries for patients. Sildenafil increases exercise capacity in low-oxygen settings.
Ann Intern Med. 2004 Aug 3;141(3):I12. doi: 10.7326/0003-4819-141-3-200408030-00001.
Zotero 插件